DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma

Acta Neuropathologica

Volumn 134, Issue 6, 2017, Pages 965-967

  Korshunov, Andrey ^a,b   Chavez, Lukas ^a   Northcott, Paul A ^c   Sharma, Tanvi ^a   Ryzhova, Marina ^d   Jones, David T W ^a   von Deimling, Andreas ^a,b   Pfister, Stefan M ^a,b   Kool, Marcel ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM TUMOR; DNA EXTRACTION; DNA METHYLATION; EPIGENETICS; EWING SARCOMA; GENE DOSAGE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; ISOCHROMOSOME; LETTER; MEDULLOBLASTOMA; MOLECULAR GENETICS; NANOSTRING METHOD; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; RNA EXTRACTION; TUMOR CLASSIFICATION; CEREBELLUM TUMOR; CLASSIFICATION; COMPARATIVE STUDY; GENETIC PROCEDURES; GENETICS; METABOLISM;

RNA;

CEREBELLAR NEOPLASMS; DNA METHYLATION; GENETIC TECHNIQUES; HUMANS; MEDULLOBLASTOMA; RNA;

EID: 85031415872     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-017-1776-9     Document Type: Letter

References (6)

1. Hovestadt V, Remke M, Kool M et al (2013) Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol 125(6):913–916. doi:10.1007/s00401-013-1126-5
2. Northcott PA, Shih DJ, Remke M et al (2012) Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 123(4):615–626. doi:10.1007/s00401-011-0899-7
3. Northcott PA, Buchhalter I, Morrissy AS et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547(7663):311–317. doi:10.1038/nature22973
4. Pietsch T, Schmidt R, Remke M et al (2014) Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol 128(1):137–149. doi:10.1007/s00401-014-1276-0
5. Ramaswamy V, Remke M, Bouffet E (2016) Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 131(6):821–831. doi:10.1007/s00401-016-1569-6
6. Sturm D, Orr BA, Toprak UH et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164(5):1060–1072. doi:10.1016/j.cell.2016.01.015